W.A. Long scite author profile

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

W.A. Long

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

444 SVR for Controlled-Release Interferon Alpha-2b (Cr2b) +Ribavirin Compared to Pegylated Interferon Alpha-2b (Peg2b) +Ribavirin in Treatment-Naive Genotype-1 (G1) Hepatitis C: Final Results From Select-2

628 Randomized Trial Comparing Systemic and Local Reactions to Controlled-Release Interferon Alpha2b and Pegylated-Interferon Alpha2b in Hepatitis C Patients Who Failed Prior Treatment

446 Timing and Frequency of Depression During HCV-Treatment With Controlled-Release-Ifna2b (Cr2b) vs. Pegylated-Ifna2b (Peg2b): Results From Select-2, a Randomized-Open-Label-72-Week-Comparison in 116 Treatment-Naive Patients With Genotype-1 HCV

Contact Info

Product

Resources

About